Frontal symptoms in substance abusers under treatment using the Spanish version of the frontal system behaviour scale;Sintomatología frontal en adictos a sustancias en tratamiento mediante la versión española de la escala de comportamiento frontal

Revista de Neurologia

Volumn 48, Issue 12, 2009, Pages 624-631

  Pedrero Perez E J ^a   Ruiz Sanchez De Leon J M ^b   Llanero Luque, M ^b   Rojo Mota, G ^a   Olivar Arroyo, A ^c   Puerta García, Carmen ^a,d  

^a Centro de Atención A Drogodependientes CAD 4   (Spain)

^b Centro de Prevencion del Deterioro Cognitivo   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Centro de Atención a Drogodependientes CAD 4 San Blas   (Spain)

Author keywords

Addiction; Apathy; DEX; Drug abuse; Drug dependence; Dysexecutive syndrome; Executive functions; Frontal cortex; Frontal lobes; FrSBe; Lack of inhibition; Neuropsychology

Indexed keywords

ADDICTION; ADULT; APATHY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; DYSEXECUTIVE SYNDROME; FEMALE; FRONTAL LOBE; FRONTAL SYSTEM BEHAVIOR SCALE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; QUESTIONNAIRE; SPAIN; SYMPTOM; SYNDROME; PATHOPHYSIOLOGY;

ADULT; FEMALE; FRONTAL LOBE; HUMANS; LANGUAGE; MALE; PSYCHOMETRICS; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS;

EID: 68949209699     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4812.2008654     Document Type: Article

References (53)

1. Verdejo A, Orozco C, Meersmans M, Aguilar F, Pérez-García M. Impacto de la gravedad del consumo de drogas de abuso sobre distintos componentes de la función ejecutiva. Rev Neurol 2004; 38: 1109-1116 (Pubitemid 39024976)
2. Papazian O, Alfonso I, Luzondo RJ. Trastornos de las funciones ejecutivas. Rev Neurol 2006; 42 (Supl 3): S45-50.
3. Jódar-Vicente M. Funciones cognitivas del lóbulo frontal. Rev Neurol 2004; 39: 178-182
4. Estévez-González A, García-Sánchez C, Barraquer-Bordas L. Los lóbulos frontales: el cerebro ejecutivo. Rev Neurol 2000; 31: 566-577 (Pubitemid 30824650)
5. Tirapu-Ustárroz J, García-Molina A, Luna-Lario P, Roig-Rovira T, Pelegrín-Valero C. Modelos de funciones y control ejecutivo (I). Rev Neurol 2008; 46: 684-692
6. Tirapu-Ustárroz J, García-Molina A, Luna-Lario P, Roig-Rovira T, Pelegrín-Valero C. Modelos de funciones y control ejecutivo (II). Rev Neurol 2008; 46: 742-750
7. Bechara A, Damasio H, Damasio AR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 2000; 10: 295-307. (Pubitemid 30159296)
8. London ED, Ernst M, Grant S, Bonson K, Weinstein A. Orbitofrontal cortex and human drug abuse: functional imaging. Cereb Cortex 2000; 10: 334-342 (Pubitemid 30159300)
9. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Be 2005; 81: 319-330 (Pubitemid 40807130)
10. Nestor L, Roberts G, Garavan H, Hester R. Deficits in learning and memory: parahippocampal hyperactivity and frontocortical hypoactivity in cannabis users. Neuroimage 2008; 40: 1328-1339
11. Verdejo A, López-Torrecillas F, Aguilar de Arcos F, Pérez-García M. Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis. Addict Behav 2004; 30: 89-101. (Pubitemid 39550441)
12. Grace J, Malloy PF. Frontal Systems Behavior Scale (FrSBe): professional manual. Lutz, FL: Psychological Assessment Resources; 2001.
13. Reid-Arndt SA, Nehl C, Hinkebein J. The Frontal Systems Behaviour Scale (FrSBe) as a predictor of community integration following a traumatic brain injury. Brain Inj 2007; 21: 1361-1369 (Pubitemid 350253440)
14. Malloy P, Tremont G, Grace J, Frakey L. The Frontal Systems Behavior Scale discriminates frontotemporal dementia from Alzheimer's disease. Alzheimer's & Dementia 2007; 3: 200-203 (Pubitemid 46825505)
15. Velligan DI, Ritch JL, Sui D, DiCocco M, Huntzinger CD. Frontal Systems Behavior Scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function. Psychiatr Res 2002; 113: 227-236 (Pubitemid 36136045)
16. Chiaravalloti ND, DeLuca J. Assessing the behavioral consequences of multiple sclerosis: an application of the Frontal Systems Behavior Scale (FrSBe). Cogn Behav Neurol 2003; 16: 54-67. (Pubitemid 37254444)
17. Grossman AB, Woolley-Levine S, Bradley WG, Miller RG. Detecting neurobehavioral changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2007; 8: 56-61. (Pubitemid 46322941)
18. McDonald CR, Norman MA, Delis DC, Tecoma ES, Iragui VJ. Cognitive inhibition, mood, and behavior in frontal lobe epilepsy: relationship to seizure lateralization and structural MRI findings [abstract]. Epilepsia 2004; 45 (Suppl 7): S346.
19. Meersmans M, López-Jiménez Á, Escamilla F, Jouma M, Ramajo S, Mínguez A, et al. Escala conductual de sistemas frontales (FrSBe) en pacientes con enfermedad de Parkinson: resultados a los 24 meses de estimulación bilateral del núcleo subtalámico. Interpsiquis 2007. URL: http://www.psiquiatria.com/articulos/neuropsiquiatria/29514 [10.01.2009].
20. Ready RE, Friedman J, Grace J, Fernandez H. Testosterone deficiency and apathy in Parkinson's disease: a pilot study. J Neurol Neurosurg Psychiatry 2004; 75: 1323-1326 (Pubitemid 39141342)
21. Boyle PA, Malloy PF, Salloway S, Cahn-Weiner DA, Cohen R, Cummings JL. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2003; 11: 214-221 (Pubitemid 36254195)
22. Davis JD, Tremont G. Impact of frontal systems behavioral functioning in dementia on caregiver burden. J Neuropsychiatry Clin Neurosci 2007; 19: 43-49 (Pubitemid 46294444)
23. Ready RE, Ott BR, Grace J, Cahn-Weiner DA. Apathy and executive dysfunction in mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 2003; 11: 222-228 (Pubitemid 36254196)
24. Stout JC, Wyman MF, Johnson SA, Peavey GM, Salmon DP. Frontal behavioral syndromes and functional status in probable Alzheimer's disease. Am J Geriatr Psychiatry 2003; 11: 683-686
25. Spinella M, Lyke J. Executive personality traits and eating behaviour. Int J Neurosci 2004; 114: 83-93. (Pubitemid 38090120)
26. Ross SR, Benning SD, Adams Z. Symptoms of executive dysfunction are endemic to secondary psychopathy: an examination in criminal offenders and noninstitutionalized young adults. J Pers Disord 2007; 21: 384-399 (Pubitemid 47281286)
27. Spinella M, Yang B, Lester D. Prefrontal system dysfunction and credit card debt. Int J Neurosci 2004; 114: 1323-1332 (Pubitemid 39243554)
28. Dimoska A, Johnstone SJ. Neural mechanisms underlying trait impulsivity in non-clinical adults: stop-signal performance and event-related potentials. Prog Neuropsychopharmacol 2007; 31: 443-454 (Pubitemid 46210230)
29. Hoerold D, Dockree PM, O'Keeffe FM, Bates H, Pertl M, Robertson IH. Neuropsychology of self-awareness in young adults. Exp Brain Res 2008; 186: 509-515
30. Spinella M. Prefrontal substrates of empathy: psychometric evidence in a community sample. Biol Psychol 2005; 70: 175-181 (Pubitemid 41464597)
31. Spinella M. Measuring the executive regulation of emotion with self-rating scales in a nonclinical population. J Gen Psychol 2007; 134: 101-111
32. Stout JC, Ready RE, Grace J, Malloy PF, Paulsen JS. Factor analysis of the Frontal Systems Behavior Scale (FrSBe). Assessment 2003; 10: 79-85. (Pubitemid 44534450)
33. Spinella M. Relationship between drug use and prefrontal associated traits. Addict Biol 2003; 8: 67-74. (Pubitemid 36433982)
34. Verdejo A, Rivas C, López-Torrecillas F, Pérez- García M. Differential impact of severity of drug use on frontal behavioral symptoms. Addict Behav 2006; 31: 1373-1382 (Pubitemid 44093863)
35. Verdejo A, Pérez-García M. Substance abusers' self-awareness of the neurobehavioral consequences of addiction. Psychiatry Res 2008; 158: 172-180
36. Verdejo A, Bechara A, Recknor EC, Pérez-García M. Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc 2006; 12: 405-415 (Pubitemid 43970906)
37. Caracuel A, Verdejo A, Vilar R, Pérez-García M, Salinas I, Cuberos G, et al. Frontal behavioral and emotional symptoms in Spanish individuals with acquired brain injury and substance use disorders. Arch Clin Neuropsychol 2008; 23: 447-454
38. Goodman LA. Snowball sampling. Ann Math Stat 1961; 32: 148-170
39. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioural assessment of the dysexecutive syndrome. Bury St. Edmunds, UK: Thames Valley Test; 1996.
40. Pedrero EJ, Ruiz-Sánchez de León JM, Rojo G, Llanero M, Olivar A, Bouso JC, et al. Versión española del cuestionario disejecutivo (DEX-Sp): propiedades psicométricas en adictos y población no clínica. Adicciones [in press].
41. Llanero M, Ruiz-Sánchez de León JM, Pedrero EJ, Olivar A, Bouso JC, Rojo G, et al. Sintomatología disejecutiva en adictos a sustancias en tratamiento mediante la versión española del cuestionario disejecutivo (DEX-Sp). Rev Neurol 2008; 47: 457-463
42. Bobes J, González MP, Saiz PA, Bousoño M. Índice europeo de severidad de la adicción: EuropASI. Versión española. Actas de la IV Reunión Interregional de Psiquiatría 1996. p. 201-218
43. Hattie J. An empirical study of the various indices for determining unidimensionality. Multivar Behav Res 1985; 19: 49-78.
44. Hu L, Bentler P. Evaluating model fit. In Hoyle R, ed. Structural equation modelling: concepts, issues and applications. Thousand Oaks, CA: Sage Publications; 1995. p. 76-99.
45. Carmines E, McIver J. Analyzing models with unobserved variables: analysis of covariance structures. In Bohrnstedt G, Borgatta E, eds. Social measurement: current issues. Beverly Hills CA: Sage; 1981. p. 65-115.
46. Gottschalk PC, Kosten TR. Cerebral perfusion defects in combined cocaine and alcohol dependence. Drug Alcohol Depend 2002; 68: 95-104.
47. Verdejo A, Aguilar F, Pérez-García M. Alteraciones de los procesos de toma de decisiones vinculados al córtex prefrontal ventromedial en pacientes drogodependientes. Rev Neurol 2004; 38: 601-606 (Pubitemid 38788522)
48. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci 2005; 8: 1458-1463 (Pubitemid 41573656)
49. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, et al. Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998; 10: 314-319
50. Adrián JE. Relaciones entre el lenguaje materno sobre términos verbales cognitivos y la comprensión infantil de estados mentales [tesis doctoral]. Castellón: Universitat Jaume I; 2002.
51. Deaño M, Fernández-Dopazo MC. Déficit de atención con hiperactividad (TDAH), procesos Pass y eficacia de un programa de intervención cognitiva. Educación, Desarrollo y Diversidad 2004; 7; 51-92.
52. Ruiz-Sánchez de León JM, Pedrero EJ, Bouso JC, Llanero M, Rojo G, Olivar A, et al. Perfil neuropsicológico en la adicción a la cocaína: consideraciones sobre el ambiente social próximo de los adictos y el valor predictivo del estado cognitivo en el éxito terapéutico. Adicciones [in press].
53. Wilens T. The nature of the relationship between attention-deficit/ hyperactivity disorder and substance use. J Clin Psychiatry 2007; 68 (Suppl 11): S4-8. (Pubitemid 47606855)